Research location

Bad Krozingen

Germany

Published trials60

Site observations63

Linked trials published60

Page1 / 2

Research activity in Bad Krozingen

Germany

CureCurrent currently publishes aggregate city-level research activity for this location: 60 trials and 63 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Bad Krozingen

60 linked trials · page 1 of 2

BIO|STREAM.CSP StudyNCT07393009 · 2026-05-25 · 1 site observation

Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE StudyNCT07276139 · 2026-01-01 · 1 site observation

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurENCT07515508 · 2024-08-07 · 1 site observation

The ReTAVI Prospective Observational RegistryNCT05601453 · 2023-09-05 · 1 site observation

The "Global Paradise System" RegistryNCT05027685 · 2022-01-13 · 1 site observation

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightNCT06858878 · 2025-03-17 · 1 site observation

ACTIVE_NOT_RECRUITING

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightNCT06858839 · 2025-03-12 · 1 site observation

ACTIVE_NOT_RECRUITING

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple SclerosisNCT06551519 · 2024-10-23 · 1 site observation

ACTIVE_NOT_RECRUITING

Early Genetic Identification of ObesityNCT06239064 · 2024-01-24 · 1 site observation

ACTIVE_NOT_RECRUITING

RESPONDER-HF TrialNCT05425459 · 2022-11-17 · 1 site observation

ACTIVE_NOT_RECRUITING

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.NCT05408039 · 2022-07-14 · 1 site observation

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus GlobalNCT04236609 · 2020-06-15 · 1 site observation

Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart FailureNCT03494933 · 2018-09-01 · 1 site observation

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MINCT02924727 · 2016-12-09 · 1 site observation

First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant HypertensionNCT03314012 · 2015-12-11 · 1 site observation

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation SystemNCT02439775 · 2015-07-22 · 1 site observation

SPYRAL PIVOTAL - SPYRAL HTN-OFF MED StudyNCT02439749 · 2015-06-01 · 1 site observation

Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation

Prospective Study With AMI Patients Undergoing PCINCT03038360 · 2014-09-10 · 1 site observation

Optisure Lead Post Approval StudyNCT02235545 · 2014-08-01 · 1 site observation

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation TherapyNCT02173769 · 2014-06-01 · 1 site observation

Renal Denervation in Patients With Chronic Heart FailureNCT02085668 · 2014-05-01 · 1 site observation

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation

LifeVest Trends Validation ProtocolNCT02149290 · 2014-02-01 · 1 site observation

Safety and Tolerability of Initiating LCZ696 in Heart Failure PatientsNCT01922089 · 2013-11-01 · 1 site observation

Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 1 site observation

A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral RegurgitationNCT01772108 · 2013-04-01 · 1 site observation

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart FailureNCT01786512 · 2013-02-26 · 1 site observation

IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNNCT01705080 · 2013-01-17 · 1 site observation

TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE)NCT01789918 · 2013-01-09 · 1 site observation

Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilationNCT01164592 · 2012-08-01 · 1 site observation

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s DiseaseNCT01606670 · 2012-05-01 · 1 site observation

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)NCT01585298 · 2012-04-29 · 1 site observation

An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical PracticeNCT01480063 · 2012-04-16 · 1 site observation

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple SclerosisNCT01201356 · 2010-09-13 · 1 site observation

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) PatientsNCT01127750 · 2010-05-01 · 1 site observation

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation

Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExampleNCT01036763 · 2010-01-01 · 1 site observation

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)NCT00888433 · 2009-06-01 · 1 site observation

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart FailureNCT00923156 · 2009-05-01 · 1 site observation

European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation

Renal Denervation in Patients With Refractory HypertensionNCT00664638 · 2008-04-01 · 1 site observation

Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart FailureNCT00733343 · 2008-02-01 · 3 site observations

Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionNCT00760214 · 2008-01-01 · 1 site observation

Atrial Fibrillation Management in Congestive Heart Failure With AblationNCT00652522 · 2008-01-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.